ImmuCell Corporation Company Profile
NASDAQ: ICCCHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD
9.75+0.06 (+0.62%)
Market open · Delayed 15 min · as of Oct 8, 2:43 PM ET
ImmuCell at a glance
ImmuCell Corporation (NASDAQ: ICCC) is a Biotechnology: In Vitro & In Vivo Diagnostic Substances company in the Health Care sector. The company's shares have traded publicly since 1987. At a market capitalization of $88.0 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0000811641, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- ImmuCell Corporation
- Ticker
- NASDAQ: ICCC
- Sector
- Health Care
- Industry
- Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Headquarters
- United States
- IPO year
- 1987
- Market cap
- $88.01M
- SEC CIK
- 0000811641
Companies similar to ImmuCell
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| IMDXInsight Molecular Diagnostics Inc. | 3.22 | -6.94% | $105.37M | vs ICCC |
| BMRABiomerica Inc. | 1.87 | -1.58% | $8.60M | vs ICCC |
| VNRXVolitionRX Limited | 0.2212 | -2.12% | $6.65M | vs ICCC |
| CDIOCardio Diagnostics Holdings Inc. | 1.89 | -4.08% | $5.59M | vs ICCC |
| QCLSQ/C Technologies Inc. | 0.6343 | +0.36% | $5.19M | vs ICCC |
| TRIBTrinity Biotech plc ADR | 6.12 | -9.68% | $4.98M | vs ICCC |
| VRAXVirax Biolabs Group Limited | 1.96 | -7.11% | $2.64M | vs ICCC |
| NNNNAnbio Biotechnology Class A | 4.57 | -6.73% | $200.58M | vs ICCC |